Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

(2010) C. N. Hayes et al.   GUT

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

(2010) Norio Akuta et al.   HEPATOLOGY

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

(2010) Marco Antonio Montes-Cano et al.   HEPATOLOGY

Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor

(2010) N. Kamiya et al.   JOURNAL OF GENERAL VIROLOGY

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

(2010) Thomas Vanwolleghem et al.   JOURNAL OF HEPATOLOGY

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients

(2010) Hiromi Abe et al.   JOURNAL OF HEPATOLOGY

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

(2009) Tania Mara Welzel et al.   HEPATOLOGY

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

(2009) Takeshi Okanoue et al.   JOURNAL OF GASTROENTEROLOGY

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

(2009) Nami Mori et al.   JOURNAL OF MEDICAL VIROLOGY

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

(2009) Norio Akuta et al.   JOURNAL OF MEDICAL VIROLOGY

Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms

(2009) F. J. Eng et al.   JOURNAL OF VIROLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice

(2008) T. Kimura et al.   JOURNAL OF GENERAL VIROLOGY

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA